logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Cowen, Andrew Edward
    Born in February 1958
    Individual (11 offsprings)
    Officer
    icon of calendar 2012-06-12 ~ now
    OF - Director → CIF 0
  • 2
    Richards, Michael Roy
    Born in July 1951
    Individual (5 offsprings)
    Officer
    icon of calendar 2012-06-25 ~ now
    OF - Director → CIF 0
    Richards, Michael Roy
    Individual (5 offsprings)
    Officer
    icon of calendar 2012-06-25 ~ now
    OF - Secretary → CIF 0
  • 3
    BIOPHARMA PROCESS SYSTEMS LIMITED
    icon of addressBiopharma House, Winnall Valley Road, Winchester, Hampshire, England
    Active Corporate (7 parents, 1 offspring)
    Equity (Company account)
    9,390,452 GBP2024-12-31
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 1
  • Cowen, Andrew
    Individual (11 offsprings)
    Officer
    icon of calendar 2012-06-12 ~ 2012-06-25
    OF - Secretary → CIF 0
parent relation
Company in focus

BIOPHARMA OVERSEAS LIMITED

Standard Industrial Classification
70100 - Activities Of Head Offices
Brief company account
Fixed Assets - Investments
6,354 GBP2024-12-31
6,354 GBP2023-12-31
Debtors
304,089 GBP2024-12-31
105,596 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-310,442 GBP2024-12-31
-111,949 GBP2023-12-31
Net Current Assets/Liabilities
-6,353 GBP2024-12-31
-6,353 GBP2023-12-31
Total Assets Less Current Liabilities
1 GBP2024-12-31
1 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
Average Number of Employees
22024-01-01 ~ 2024-12-31
22023-01-01 ~ 2023-12-31
Investments in group undertakings and participating interests
6,354 GBP2024-12-31
6,354 GBP2023-12-31
Amounts Owed By Related Parties
304,089 GBP2024-12-31
Current
105,596 GBP2023-12-31
Amounts owed to group undertakings
Current
310,442 GBP2024-12-31
111,949 GBP2023-12-31

  • BIOPHARMA OVERSEAS LIMITED
    Info
    Registered number 08102654
    icon of addressBiopharma House, 9 Winnall Valley Road, Winchester, Hampshire SO23 0LD
    PRIVATE LIMITED COMPANY incorporated on 2012-06-12 (13 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2025-06-12
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.